Updated Jul 16, 2026
Gall Matthew has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $39K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-05 | TNGX | Tango Therapeutics, Inc. | A — Grant or award | 40.0K | $0.00 | |
| 2025-08-29 | ITOS | iTeos Therapeutics, Inc. | J — Other acquisition / disposition | 89.4K | — | |
| 2024-11-19 | ITOS | iTeos Therapeutics, Inc. | P — Open-market purchase | 5.0K | $7.73 | $39K |
Gall Matthew is a corporate insider — currently tracked as Insider of Tango Therapeutics, Inc. (TNGX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($39K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Gall Matthew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.